Hudson Bay Capital Management LP Vir Biotechnology, Inc. Transaction History
Hudson Bay Capital Management LP
- $21.9 Billion
- Q3 2024
A detailed history of Hudson Bay Capital Management LP transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 528,242 shares of VIR stock, worth $5.76 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
528,242
Previous 425,000
24.29%
Holding current value
$5.76 Million
Previous $3.78 Million
4.6%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding VIR
# of Institutions
214Shares Held
87MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$182 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$179 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$143 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$61.3 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$38.9 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.45B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...